Pitavastatin and Atorvastatin
Showing 1 - 25 of 755
Chronic Kidney Disease Trial in Beijing (Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin)
Recruiting
- Chronic Kidney Disease
- Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
-
Beijing, ChinaPeking University Third Hospital
Feb 27, 2023
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
- Pitavastatin
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 29, 2023
Acute Myocardial Infarction, Glucose Metabolism Disorders Trial in Beijing (Pitavastatin, Atorvastatin)
Recruiting
- Acute Myocardial Infarction
- Glucose Metabolism Disorders
-
Beijing, Beijing, ChinaFuwai Hospital
May 7, 2022
Chronic Kidney Disease Trial in Busan (Pitavastatin, Atorvastatin)
Completed
- Chronic Kidney Disease
-
Busan, Korea, Republic of
- +1 more
Sep 18, 2021
Real World Evidence Study of Statin Use in Brazil
Completed
- Cardiovascular Diseases
- +5 more
-
São Paulo, SP, BrazilHospital Israelita Albert Einstein
Mar 16, 2022
Renal Insufficiency Trial in Hialeah, Orlando (Midazolam oral solution, Dabigatran and pitavastatin oral solution, Atorvastatin
Completed
- Renal Insufficiency
- Midazolam oral solution
- +3 more
-
Hialeah, Florida
- +1 more
Dec 19, 2019
Hypercholesterolemia With Type2DM Trial (Pitavastatin, Atorvastatin)
Completed
- Hypercholesterolemia With Type2DM
- (no location specified)
Aug 26, 2019
Drug Interaction Trial in San Antonio (Ecopipam, Cohort 1 Probe Substrate Cocktail, Cohort 2 Probe Substrate)
Completed
- Drug Interaction
- Ecopipam
- +3 more
-
San Antonio, TexasICON Early Phase Services
Dec 9, 2022
Heart Failure With Reduced Ejection Fraction Trial in Chandigarh (Atorvastatin Oral Tablet, Rosuvastatin Oral Tablet)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Atorvastatin Oral Tablet
- Rosuvastatin Oral Tablet
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research, Chandi
Oct 11, 2021
Prediabetic State, Hypertension, Dyslipidemias Trial in China (Pitavastatin Calcium, Atorvastatin Calcium)
Unknown status
- Prediabetic State
- +2 more
- Pitavastatin Calcium
- Atorvastatin Calcium
-
Chongqing, Chongqing, China
- +12 more
May 31, 2019
Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,
Not yet recruiting
- Acute Coronary Syndrome
- Non ST Segment Elevation Acute Coronary Syndrome
- Tafolecimab
- +2 more
- (no location specified)
Oct 20, 2023
Glioblastoma Multiforme, Adult, Recurrent Glioblastoma Trial in Rotterdam (Pitavastatin calcium)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Recurrent Glioblastoma
- Pitavastatin calcium
-
Rotterdam, NetherlandsErasmus MC
Aug 3, 2023
Drug-Interactions Trial in Miami (ecopipam HCl ~2mg/kg/day, Cohort 1 Probe Cocktail, Cohort 2 Probe Cocktail)
Terminated
- Drug-Interactions
- ecopipam HCl ~2mg/kg/day
- +3 more
-
Miami, FloridaSyneos Health Clinical Research Services, LLC.
May 20, 2021
Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder Trial in Moscow (Pitavastatin, PCSK9 inhibitor)
Recruiting
- Dyslipidemias
- +5 more
- Pitavastatin
- PCSK9 inhibitor
-
Moscow, Russian FederationNational Medical Research Centre for Therapy and Preventive Medi
Sep 8, 2022
Renal Protection Trial in Minia (Atorvastatin 40 Mg Oral Tablet, drug)
Recruiting
- Renal Protection
- Atorvastatin 40 Mg Oral Tablet
- placebo drug
-
Minia, Minia University, EgyptMina Maher Raouf
Jul 6, 2023
Healthy Volunteers Trial in Toronto (Obicetrapib, Atorvastatin Calcium, Rosuvastatin Calcium)
Not yet recruiting
- Healthy Volunteers
- Obicetrapib
- +2 more
-
Toronto, Ontario, CanadaMark M Feldman
Oct 10, 2023
PREPARE (A5361s) Substudy of REPRIEVE (A5332)
Active, not recruiting
- HIV-1 Infection
- Pitavastatin
- Placebos
-
Birmingham, Alabama
- +32 more
Dec 7, 2022
Primary Hypercholesterolemia Trial in Seoul (Livalo, Ezetrol)
Completed
- Primary Hypercholesterolemia
- Livalo, Ezetrol
-
Seoul, Korea, Korea, Republic ofGangdong Sacred Heart Hospital
Nov 29, 2021
Liver Cirrhoses Trial in Hvidovre (Placebo oral tablet, Atorvastatin 10mg)
Terminated
- Liver Cirrhoses
- Placebo oral tablet
- Atorvastatin 10mg
-
Hvidovre, Danmark, DenmarkGastro Unit, medical Division, University Hospital Hvidovre
Jan 11, 2023
Acute Metabolic Effects of Evolocumab and Atorvastatin Trial (Evolocumab)
Not yet recruiting
- Acute Metabolic Effects of Evolocumab and Atorvastatin
- (no location specified)
Nov 16, 2023
Dyslipidemias, Atherosclerosis, Diabetes, Type 2 Trial (Omega 3-Atorvastatin, Atorvastatin-Ezetimibe)
Recruiting
- Dyslipidemias
- +2 more
- Omega 3-Atorvastatin
- Atorvastatin-Ezetimibe
-
Seongnam, Gyeonggi, Korea, Republic ofSNUBH
Oct 1, 2022
Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Doxorubicin Induced Cardiomyopathy
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Cairo, EgyptAin Shams University hospitals
Apr 4, 2023
Primary Hypercholesterolemia, Mixed Dyslipidemias Trial in Australia, New Zealand, Taiwan (Pitavastatin, Ezetimibe, 1PC111)
Completed
- Primary Hypercholesterolemia
- Mixed Dyslipidemias
- Pitavastatin
- +2 more
-
Blacktown, Australia
- +33 more
May 17, 2022
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe)
Completed
- Dyslipidemias
- Observational
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Apr 1, 2021